approved EB-1B
Senior Scientist
Nanomedicine · 2025-12-05
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 2 criteria metScholarly Publications (Met)
The petitioner authored 14 peer-reviewed journal articles and 1 conference paper in the field of nanomedicine.
Original Research Contributions (Met)
The petitioner's work on human serum albumin nanoparticles provided significant advancements in drug delivery platforms.
Peer Review Judging (Met)
The petitioner completed peer reviews for at least 13 manuscripts for journals in their field.
Why This Petition Was Approved
The approval was based on the petitioner's 1,399 citations and authorship of 14 peer-reviewed journal articles, including 4 first-authored papers. The case demonstrated international recognition through citations spanning five continents and a record of peer-reviewing at least 13 manuscripts. These metrics satisfied the EB-1B criteria for outstanding research contributions and scholarly publications.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
- 1,399 citations
- 14 peer-reviewed journal articles (4 first-authored)
- 1 peer-reviewed conference paper
- 7 first-authored abstracts
- Peer review service for at least 13 manuscripts
- Citations spanning five continents
- Four expert recommendation letters
Similar Cases
Research Scientist
Research and Development · India
WeGreened EB-1B approved
Pennsylvania 9 days 2022-12-07
The petition was approved based on the petitioner's Ph.D. and 9 years of contributions, including 9 peer-reviewed scientific articles in high-impact journals. His work garnered 37 citations and he completed over 127 peer reviews for journals and conferences. These metrics satisfied the EB-1B criteria for scholarly publications, original contributions, and judging the work of others.
Research Assistant
Pharmaceuticals · China
WeGreened EB-1B approved
Minnesota 761 days 2025-04-01
The petition was approved based on the petitioner's 15 peer-reviewed articles and 215 citations, with several papers ranking in the top 10% of the field. Additionally, her participation in 10 peer reviews for prestigious journals and the global application of her research by independent scholars satisfied the EB-1B requirements.
Assistant Professor
Materials Science · India
WeGreened EB-1B approved
Oklahoma 480 days 2025-12-16
The approval was based on a strong record of 44 peer-reviewed journal articles and 1,127 citations demonstrating sustained influence. The petitioner also provided evidence of 3 licensed patents and a textbook. Furthermore, the petitioner satisfied the peer review criterion by completing at least 21 manuscript reviews for respected journals.
Postdoctoral Researcher
Biotechnology · China
WeGreened EB-1B rfe approved
Massachusetts 557 days 2025-10-20
The petition was approved based on the petitioner's 14 peer-reviewed journal articles and 655 citations, which established his international influence in cell biology. His completion of 25 peer reviews for leading journals satisfied the judging criteria for EB-1B. The evidence successfully demonstrated his original scientific research contributions to the field of cancer treatment and molecular biochemistry.
Frequently Asked Questions
A approved EB-1B (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-12-05.
Browse all casesAt a Glance
Outcome approved
Processing 16 days
Criteria Met 3 / 2
Evidence Types 5
EB-1B Case Data
Scraped Case Data
Total Cases 63
Success Rate 98.4%
Sustained 62
Dismissed 1
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist